Lidocaine Hydrochloride

Product NDC: 50383-775
11-digit product format: 503830775
Labeler code: 50383
Product ID: 50383-775_52742732-33c5-407f-87fd-9925977b8cb0
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Lidocaine Hydrochloride
Dosage form: SOLUTION
Route: ORAL; TOPICAL
Labeler: Akorn
Application: ANDA040014
Marketing category: ANDA
Marketing start: 1995-07-10
Marketing end: 0000-00-00
Substance: LIDOCAINE HYDROCHLORIDE ANHYDROUS
Active strength: 20 mg/mL
Pharmacologic classes: Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]
NDC exclude flag: No
Listing certified through: 2023-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 3 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	50383-775		D	Discontinued by firm	2026-08-10
excluded package	package	50383-775	50383-775-04	D	Discontinued by firm	2026-08-10
excluded package	package	50383-775	50383-775-17	D	Discontinued by firm	2026-08-10

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 33 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	50383-775-04	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	50383-775-17	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	50383-775-17	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	50383-775-04	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	50383-775-17	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	50383-775-04	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	50383-775-17	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	50383-775-04	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	50383-775-17	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	50383-775-04	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	50383-775-17	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	50383-775-04	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	50383-775-17	I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	50383-775-04	I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	50383-775-17	I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	50383-775-04	I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	50383-775-17	I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	50383-775-04	I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	50383-775-17	I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	50383-775-04	I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	50383-775-17	I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	50383-775-04	I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A040014-001	LIDOCAINE HYDROCHLORIDE	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION / ORAL			1995-07-10

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 41 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	RLD / RS	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A040014-001	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION / ORAL			1995-07-10	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A040014-001	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION / ORAL			1995-07-10	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A040014-001	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION / ORAL			1995-07-10	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A040014-001	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION / ORAL			1995-07-10	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A040014-001	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION / ORAL			1995-07-10	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A040014-001	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION / ORAL			1995-07-10	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A040014-001	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION / ORAL			1995-07-10	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A040014-001	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION / ORAL			1995-07-10	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A040014-001	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION / ORAL			1995-07-10	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A040014-001	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION / ORAL			1995-07-10	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A040014-001	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION / ORAL			1995-07-10	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A040014-001	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION / ORAL			1995-07-10	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A040014-001	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION / ORAL			1995-07-10	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A040014-001	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION / ORAL			1995-07-10	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A040014-001	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION / ORAL	AT	RS	1995-07-10	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A040014-001	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION / ORAL	AT	RS	1995-07-10	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A040014-001	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION / ORAL	AT	RS	1995-07-10	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A040014-001	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION / ORAL	AT		1995-07-10	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A040014-001	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION / ORAL	AT	RS	1995-07-10	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A040014-001	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION / ORAL	AT	RS	1995-07-10	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A040014-001	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION / ORAL	AT	RS	1995-07-10	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A040014-001	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION / ORAL	AT	RS	1995-07-10	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A040014-001	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION / ORAL	AT	RS	1995-07-10	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A040014-001	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION / ORAL	AT	RS	1995-07-10	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A040014-001	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION / ORAL	AT		1995-07-10	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A040014-001	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION / ORAL	AT		1995-07-10	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A040014-001	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION / ORAL	AT		1995-07-10	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A040014-001	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION / ORAL			1995-07-10	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	A040014-001	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION / ORAL			1995-07-10	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	A040014-001	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION / ORAL			1995-07-10	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A040014-001	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION / ORAL	AT	RS	1995-07-10	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A040014-001	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION / ORAL	AT	RS	1995-07-10	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A040014-001	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION / ORAL	AT	RS	1995-07-10	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A040014-001	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION / ORAL	AT	RS	1995-07-10	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	A040014-001	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION / ORAL	AT	RS	1995-07-10	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	A040014-001	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION / ORAL	AT	RS	1995-07-10	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A040014-001	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION / ORAL	AT	RS	1995-07-10	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	A040014-001	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION / ORAL	AT	RS	1995-07-10	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	A040014-001	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION / ORAL	AT	RS	1995-07-10	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	A040014-001	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION / ORAL	AT	RS	1995-07-10	`cb3db0bc1861…`

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A040014-001	AT	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A040014-001	AT	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A040014-001	AT	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A040014-001	AT	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A040014-001	AT	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A040014-001	AT	1	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A040014-001	AT	1	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A040014-001	AT	1	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A040014-001	AT	1	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A040014-001	AT	1	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A040014-001	AT	1	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A040014-001	AT	1	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A040014-001	AT	1	`ea99ee380514…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A040014-001	AT	1	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A040014-001	AT	1	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A040014-001	AT	1	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A040014-001	AT	1	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	A040014-001	AT	1	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	A040014-001	AT	1	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A040014-001	AT	1	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	A040014-001	AT	1	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	A040014-001	AT	1	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	A040014-001	AT	1	`cb3db0bc1861…`

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
070fbed5-7088-434a-a7ce-f2a64d8d40ac	Product name	2	20260107
bee66ce1-adb7-9d3b-67d9-582e4c54e80f	Product name	5	20250819
860a93dc-4863-49cc-b284-6bbe8191bc48	Product name	4	20250214
eaba870a-6a9d-442e-8643-87b3f558a451	Product name	1	20250117
fb7ab793-2c12-4079-b100-a64f73bef25a	Product name	4	20240712
b0cbf770-6cc3-4aa4-9158-755110c2b9f7	Product name	2	20230717
dc7c5daa-021f-40dd-b00d-63982cb2067a	Product name	1	20230426
9b4cf230-fd05-41d5-98c6-5db9ecb27b86	Product name	1	20230117
7d755fa1-1087-4dcd-98f0-6d4bba479a57	Product name	3	20210602
08ffbcbf-26df-b99c-1dab-64fc4cfae89f	Product name	5	20200925
aed701d5-9c75-dfaf-7154-cde46179faea	Product name	9	20200313
816b97af-edc5-4060-aff1-b814bdbcad50	Product name	1	20190415
7cda52fc-125f-421c-8fea-bc1974370c49	Product name	2	20180703
fa8b5901-e681-426f-82fe-54f6d81ec698	Product name	4	20180619
332d03e4-aa24-4b11-841a-02bf41081920	Product name	1	20171221
c08ab52f-2fc8-4409-9d9f-ed8edc0bd070	Product name	1	20171221
419aab54-5d5a-4146-9453-026d4a9991be	Product name	2	20170525
08ffbcbf-26df-b99c-1dab-64fc4cfae89f	Product name	2	20160823
89dac932-b90a-4410-9ab1-84c53e57de25	Product name	1	20150316
68ed98f8-24c2-44a0-944a-6d36e82ce25a	Product name	1	20141222
1cd42bc2-a430-c72b-636d-991b235fbf80	Product name	1	20140508
49fa150c-f0de-cce7-3d9c-993ed81c5698	Product name	1	20140508
4d7ae718-ed00-bae8-2abe-9eaec1eef7ff	Product name	1	20140508
9137811f-f279-8640-5aeb-99fa2145d64d	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Related label table
NDC	Effective	Related label
50383-775-04	2025-09-12	LIDOCAINE HYDROCHLORIDE ORAL TOPICAL SOLUTION, USP (VISCOUS) 2%
50383-775-17	2025-09-12	LIDOCAINE HYDROCHLORIDE ORAL TOPICAL SOLUTION, USP (VISCOUS) 2%
50383-775-04	2024-07-30	LIDOCAINE HYDROCHLORIDE ORAL TOPICAL SOLUTION, USP (VISCOUS) 2%
50383-775-17	2024-07-30	LIDOCAINE HYDROCHLORIDE ORAL TOPICAL SOLUTION, USP (VISCOUS) 2%
50383-775-04	2024-01-30	LIDOCAINE HYDROCHLORIDE ORAL TOPICAL SOLUTION, USP (VISCOUS) 2%
50383-775-17	2024-01-30	LIDOCAINE HYDROCHLORIDE ORAL TOPICAL SOLUTION, USP (VISCOUS) 2%

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
50383-775-15	DX1 OraGenomic Medicated DNA Collection Screen	15 mL in 1 CUP, UNIT-DOSE	SOLUTION	15 mL	20 mg in 1mL	4
50383-775-15	DX2 OraGenomic Medicated DNA Collection Screen	15 mL in 1 CUP, UNIT-DOSE	SOLUTION	15 mL	20 mg in 1mL	4

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
50383-775-04	ML - Milliliter	50383-775	5bada494-1a5a-4fad-9cdc-afeabd3375f3	1	2012-07-24
50383-775-15	ML - Milliliter	50383-775	1816d2b1-9f0b-464a-b558-1cbbdc8dc27f	1	2013-11-04
50383-775-17	ML - Milliliter	50383-775	3d089f12-112d-4641-a3a4-8c49f1fa842e	1	2013-11-04

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
LIDOCAINE HYDROCHLORIDE ANHYDROUS	ACTIVE INGREDIENT	EC2CNF7XFP	LIDOCAINE HYDROCHLORIDE SOLUTION [HI-TECH PHARMACAL CO., INC.]	8
LIDOCAINE	ACTIVE MOIETY	98PI200987	LIDOCAINE HYDROCHLORIDE SOLUTION [HI-TECH PHARMACAL CO., INC.]	8
CARBOXYMETHYLCELLULOSE SODIUM	INACTIVE INGREDIENT	K679OBS311	LIDOCAINE HYDROCHLORIDE SOLUTION [HI-TECH PHARMACAL CO., INC.]	8
HYDROCHLORIC ACID	INACTIVE INGREDIENT	QTT17582CB	LIDOCAINE HYDROCHLORIDE SOLUTION [HI-TECH PHARMACAL CO., INC.]	8
METHYLPARABEN	INACTIVE INGREDIENT	A2I8C7HI9T	LIDOCAINE HYDROCHLORIDE SOLUTION [HI-TECH PHARMACAL CO., INC.]	8
ORANGE	INACTIVE INGREDIENT	5EVU04N5QU	LIDOCAINE HYDROCHLORIDE SOLUTION [HI-TECH PHARMACAL CO., INC.]	8
PROPYLPARABEN	INACTIVE INGREDIENT	Z8IX2SC1OH	LIDOCAINE HYDROCHLORIDE SOLUTION [HI-TECH PHARMACAL CO., INC.]	8
SACCHARIN SODIUM	INACTIVE INGREDIENT	SB8ZUX40TY	LIDOCAINE HYDROCHLORIDE SOLUTION [HI-TECH PHARMACAL CO., INC.]	8
SODIUM HYDROXIDE	INACTIVE INGREDIENT	55X04QC32I	LIDOCAINE HYDROCHLORIDE SOLUTION [HI-TECH PHARMACAL CO., INC.]	8
WATER	INACTIVE INGREDIENT	059QF0KO0R	LIDOCAINE HYDROCHLORIDE SOLUTION [HI-TECH PHARMACAL CO., INC.]	8
LIDOCAINE	ACTIVE INGREDIENT	98PI200987	LIDOCAINE HYDROCHLORIDE SOLUTION [UNIT DOSE SERVICES]	2
LIDOCAINE HYDROCHLORIDE	ACTIVE INGREDIENT	V13007Z41A	LIDOCAINE HYDROCHLORIDE SOLUTION [ATLANTIC BIOLOGICALS CORPS]	2
LIDOCAINE HYDROCHLORIDE	ACTIVE INGREDIENT	V13007Z41A	LIDOCAINE HYDROCHLORIDE SOLUTION [LLC FEDERAL SOLUTIONS]	2
LIDOCAINE HYDROCHLORIDE ANHYDROUS	ACTIVE INGREDIENT	EC2CNF7XFP	LIDOCAINE HYDROCHLORIDE SOLUTION [PREFERRED PHARMACEUTICALS, INC.]	2
LIDOCAINE HYDROCHLORIDE ANHYDROUS	ACTIVE INGREDIENT	EC2CNF7XFP	LIDOCAINE HYDROCHLORIDE SOLUTION [CARDINAL HEALTH]	2
LIDOCAINE	ACTIVE MOIETY	98PI200987	LIDOCAINE HYDROCHLORIDE SOLUTION [ATLANTIC BIOLOGICALS CORPS]	2
LIDOCAINE	ACTIVE MOIETY	98PI200987	LIDOCAINE HYDROCHLORIDE SOLUTION [PREFERRED PHARMACEUTICALS, INC.]	2
LIDOCAINE	ACTIVE MOIETY	98PI200987	LIDOCAINE HYDROCHLORIDE SOLUTION [CARDINAL HEALTH]	2
LIDOCAINE	ACTIVE MOIETY	98PI200987	LIDOCAINE HYDROCHLORIDE SOLUTION [LLC FEDERAL SOLUTIONS]	2
LIDOCAINE	ACTIVE MOIETY	98PI200987	LIDOCAINE HYDROCHLORIDE SOLUTION [UNIT DOSE SERVICES]	2
CARBOXYMETHYLCELLULOSE SODIUM	INACTIVE INGREDIENT	K679OBS311	LIDOCAINE HYDROCHLORIDE SOLUTION [PREFERRED PHARMACEUTICALS, INC.]	2
CARBOXYMETHYLCELLULOSE SODIUM	INACTIVE INGREDIENT	K679OBS311	LIDOCAINE HYDROCHLORIDE SOLUTION [CARDINAL HEALTH]	2
CARBOXYMETHYLCELLULOSE SODIUM	INACTIVE INGREDIENT	K679OBS311	LIDOCAINE HYDROCHLORIDE SOLUTION [ATLANTIC BIOLOGICALS CORPS]	2
CARBOXYMETHYLCELLULOSE SODIUM	INACTIVE INGREDIENT	K679OBS311	LIDOCAINE HYDROCHLORIDE SOLUTION [LLC FEDERAL SOLUTIONS]	2
CARBOXYMETHYLCELLULOSE SODIUM	INACTIVE INGREDIENT	K679OBS311	LIDOCAINE HYDROCHLORIDE SOLUTION [UNIT DOSE SERVICES]	2
HYDROCHLORIC ACID	INACTIVE INGREDIENT	QTT17582CB	LIDOCAINE HYDROCHLORIDE SOLUTION [CARDINAL HEALTH]	2
HYDROCHLORIC ACID	INACTIVE INGREDIENT	QTT17582CB	LIDOCAINE HYDROCHLORIDE SOLUTION [LLC FEDERAL SOLUTIONS]	2
HYDROCHLORIC ACID	INACTIVE INGREDIENT	QTT17582CB	LIDOCAINE HYDROCHLORIDE SOLUTION [ATLANTIC BIOLOGICALS CORPS]	2
HYDROCHLORIC ACID	INACTIVE INGREDIENT	QTT17582CB	LIDOCAINE HYDROCHLORIDE SOLUTION [PREFERRED PHARMACEUTICALS, INC.]	2
HYDROCHLORIC ACID	INACTIVE INGREDIENT	QTT17582CB	LIDOCAINE HYDROCHLORIDE SOLUTION [UNIT DOSE SERVICES]	2
METHYLPARABEN	INACTIVE INGREDIENT	A2I8C7HI9T	LIDOCAINE HYDROCHLORIDE SOLUTION [ATLANTIC BIOLOGICALS CORPS]	2
METHYLPARABEN	INACTIVE INGREDIENT	A2I8C7HI9T	LIDOCAINE HYDROCHLORIDE SOLUTION [PREFERRED PHARMACEUTICALS, INC.]	2
METHYLPARABEN	INACTIVE INGREDIENT	A2I8C7HI9T	LIDOCAINE HYDROCHLORIDE SOLUTION [CARDINAL HEALTH]	2
METHYLPARABEN	INACTIVE INGREDIENT	A2I8C7HI9T	LIDOCAINE HYDROCHLORIDE SOLUTION [LLC FEDERAL SOLUTIONS]	2
METHYLPARABEN	INACTIVE INGREDIENT	A2I8C7HI9T	LIDOCAINE HYDROCHLORIDE SOLUTION [UNIT DOSE SERVICES]	2
ORANGE	INACTIVE INGREDIENT	5EVU04N5QU	LIDOCAINE HYDROCHLORIDE SOLUTION [ATLANTIC BIOLOGICALS CORPS]	2
ORANGE	INACTIVE INGREDIENT	5EVU04N5QU	LIDOCAINE HYDROCHLORIDE SOLUTION [LLC FEDERAL SOLUTIONS]	2
ORANGE	INACTIVE INGREDIENT	5EVU04N5QU	LIDOCAINE HYDROCHLORIDE SOLUTION [UNIT DOSE SERVICES]	2
ORANGE	INACTIVE INGREDIENT	5EVU04N5QU	LIDOCAINE HYDROCHLORIDE SOLUTION [PREFERRED PHARMACEUTICALS, INC.]	2
ORANGE	INACTIVE INGREDIENT	5EVU04N5QU	LIDOCAINE HYDROCHLORIDE SOLUTION [CARDINAL HEALTH]	2
PROPYLPARABEN	INACTIVE INGREDIENT	Z8IX2SC1OH	LIDOCAINE HYDROCHLORIDE SOLUTION [PREFERRED PHARMACEUTICALS, INC.]	2
PROPYLPARABEN	INACTIVE INGREDIENT	Z8IX2SC1OH	LIDOCAINE HYDROCHLORIDE SOLUTION [UNIT DOSE SERVICES]	2
PROPYLPARABEN	INACTIVE INGREDIENT	Z8IX2SC1OH	LIDOCAINE HYDROCHLORIDE SOLUTION [LLC FEDERAL SOLUTIONS]	2
PROPYLPARABEN	INACTIVE INGREDIENT	Z8IX2SC1OH	LIDOCAINE HYDROCHLORIDE SOLUTION [ATLANTIC BIOLOGICALS CORPS]	2
PROPYLPARABEN	INACTIVE INGREDIENT	Z8IX2SC1OH	LIDOCAINE HYDROCHLORIDE SOLUTION [CARDINAL HEALTH]	2
SACCHARIN SODIUM	INACTIVE INGREDIENT	SB8ZUX40TY	LIDOCAINE HYDROCHLORIDE SOLUTION [PREFERRED PHARMACEUTICALS, INC.]	2
SACCHARIN SODIUM	INACTIVE INGREDIENT	SB8ZUX40TY	LIDOCAINE HYDROCHLORIDE SOLUTION [CARDINAL HEALTH]	2
SACCHARIN SODIUM	INACTIVE INGREDIENT	SB8ZUX40TY	LIDOCAINE HYDROCHLORIDE SOLUTION [LLC FEDERAL SOLUTIONS]	2
SACCHARIN SODIUM DIHYDRATE	INACTIVE INGREDIENT	SB8ZUX40TY	LIDOCAINE HYDROCHLORIDE SOLUTION [UNIT DOSE SERVICES]	2
SACCHARIN SODIUM DIHYDRATE	INACTIVE INGREDIENT	SB8ZUX40TY	LIDOCAINE HYDROCHLORIDE SOLUTION [ATLANTIC BIOLOGICALS CORPS]	2
SODIUM HYDROXIDE	INACTIVE INGREDIENT	55X04QC32I	LIDOCAINE HYDROCHLORIDE SOLUTION [CARDINAL HEALTH]	2
SODIUM HYDROXIDE	INACTIVE INGREDIENT	55X04QC32I	LIDOCAINE HYDROCHLORIDE SOLUTION [UNIT DOSE SERVICES]	2
SODIUM HYDROXIDE	INACTIVE INGREDIENT	55X04QC32I	LIDOCAINE HYDROCHLORIDE SOLUTION [PREFERRED PHARMACEUTICALS, INC.]	2
SODIUM HYDROXIDE	INACTIVE INGREDIENT	55X04QC32I	LIDOCAINE HYDROCHLORIDE SOLUTION [ATLANTIC BIOLOGICALS CORPS]	2
WATER	INACTIVE INGREDIENT	059QF0KO0R	LIDOCAINE HYDROCHLORIDE SOLUTION [CARDINAL HEALTH]	2
WATER	INACTIVE INGREDIENT	059QF0KO0R	LIDOCAINE HYDROCHLORIDE SOLUTION [UNIT DOSE SERVICES]	2
WATER	INACTIVE INGREDIENT	059QF0KO0R	LIDOCAINE HYDROCHLORIDE SOLUTION [LLC FEDERAL SOLUTIONS]	2
WATER	INACTIVE INGREDIENT	059QF0KO0R	LIDOCAINE HYDROCHLORIDE SOLUTION [ATLANTIC BIOLOGICALS CORPS]	2
WATER	INACTIVE INGREDIENT	059QF0KO0R	LIDOCAINE HYDROCHLORIDE SOLUTION [PREFERRED PHARMACEUTICALS, INC.]	2
LIDOCAINE HYDROCHLORIDE	ACTIVE INGREDIENT	V13007Z41A	LIDOCAINE HYDROCHLORIDE SOLUTION [REBEL DISTRIBUTORS CORP]	1
LIDOCAINE HYDROCHLORIDE	ACTIVE INGREDIENT	V13007Z41A	LIDOCAINE HYDROCHLORIDE SOLUTION [STAT RX LLC USA]	1
LIDOCAINE HYDROCHLORIDE	ACTIVE INGREDIENT	V13007Z41A	LIDOCAINE HYDROCHLORIDE SOLUTION [PHYSICIANS TOTAL CARE, INC.]	1
LIDOCAINE	ACTIVE MOIETY	98PI200987	LIDOCAINE HYDROCHLORIDE SOLUTION [STAT RX LLC USA]	1
LIDOCAINE	ACTIVE MOIETY	98PI200987	LIDOCAINE HYDROCHLORIDE SOLUTION [PHYSICIANS TOTAL CARE, INC.]	1
LIDOCAINE	ACTIVE MOIETY	98PI200987	LIDOCAINE HYDROCHLORIDE SOLUTION [REBEL DISTRIBUTORS CORP]	1
CARBOXYMETHYLCELLULOSE SODIUM	INACTIVE INGREDIENT	K679OBS311	LIDOCAINE HYDROCHLORIDE SOLUTION [PHYSICIANS TOTAL CARE, INC.]	1
CARBOXYMETHYLCELLULOSE SODIUM	INACTIVE INGREDIENT	K679OBS311	LIDOCAINE HYDROCHLORIDE SOLUTION [STAT RX LLC USA]	1
CARBOXYMETHYLCELLULOSE SODIUM	INACTIVE INGREDIENT	K679OBS311	LIDOCAINE HYDROCHLORIDE SOLUTION [REBEL DISTRIBUTORS CORP]	1
HYDROCHLORIC ACID	INACTIVE INGREDIENT	QTT17582CB	LIDOCAINE HYDROCHLORIDE SOLUTION [STAT RX LLC USA]	1
HYDROCHLORIC ACID	INACTIVE INGREDIENT	QTT17582CB	LIDOCAINE HYDROCHLORIDE SOLUTION [PHYSICIANS TOTAL CARE, INC.]	1
HYDROCHLORIC ACID	INACTIVE INGREDIENT	QTT17582CB	LIDOCAINE HYDROCHLORIDE SOLUTION [REBEL DISTRIBUTORS CORP]	1
METHYLPARABEN	INACTIVE INGREDIENT	A2I8C7HI9T	LIDOCAINE HYDROCHLORIDE SOLUTION [STAT RX LLC USA]	1
METHYLPARABEN	INACTIVE INGREDIENT	A2I8C7HI9T	LIDOCAINE HYDROCHLORIDE SOLUTION [PHYSICIANS TOTAL CARE, INC.]	1
METHYLPARABEN	INACTIVE INGREDIENT	A2I8C7HI9T	LIDOCAINE HYDROCHLORIDE SOLUTION [REBEL DISTRIBUTORS CORP]	1
ORANGE	INACTIVE INGREDIENT	5EVU04N5QU	LIDOCAINE HYDROCHLORIDE SOLUTION [REBEL DISTRIBUTORS CORP]	1
ORANGE	INACTIVE INGREDIENT	5EVU04N5QU	LIDOCAINE HYDROCHLORIDE SOLUTION [PHYSICIANS TOTAL CARE, INC.]	1
ORANGE	INACTIVE INGREDIENT	5EVU04N5QU	LIDOCAINE HYDROCHLORIDE SOLUTION [STAT RX LLC USA]	1
PROPYLPARABEN	INACTIVE INGREDIENT	Z8IX2SC1OH	LIDOCAINE HYDROCHLORIDE SOLUTION [REBEL DISTRIBUTORS CORP]	1
PROPYLPARABEN	INACTIVE INGREDIENT	Z8IX2SC1OH	LIDOCAINE HYDROCHLORIDE SOLUTION [STAT RX LLC USA]	1
PROPYLPARABEN	INACTIVE INGREDIENT	Z8IX2SC1OH	LIDOCAINE HYDROCHLORIDE SOLUTION [PHYSICIANS TOTAL CARE, INC.]	1
SACCHARIN SODIUM	INACTIVE INGREDIENT	SB8ZUX40TY	LIDOCAINE HYDROCHLORIDE SOLUTION [REBEL DISTRIBUTORS CORP]	1
SACCHARIN SODIUM	INACTIVE INGREDIENT	SB8ZUX40TY	LIDOCAINE HYDROCHLORIDE SOLUTION [PHYSICIANS TOTAL CARE, INC.]	1
SACCHARIN SODIUM	INACTIVE INGREDIENT	SB8ZUX40TY	LIDOCAINE HYDROCHLORIDE SOLUTION [STAT RX LLC USA]	1
SODIUM HYDROXIDE	INACTIVE INGREDIENT	55X04QC32I	LIDOCAINE HYDROCHLORIDE SOLUTION [REBEL DISTRIBUTORS CORP]	1
SODIUM HYDROXIDE	INACTIVE INGREDIENT	55X04QC32I	LIDOCAINE HYDROCHLORIDE SOLUTION [STAT RX LLC USA]	1
SODIUM HYDROXIDE	INACTIVE INGREDIENT	55X04QC32I	LIDOCAINE HYDROCHLORIDE SOLUTION [PHYSICIANS TOTAL CARE, INC.]	1
WATER	INACTIVE INGREDIENT	059QF0KO0R	LIDOCAINE HYDROCHLORIDE SOLUTION [REBEL DISTRIBUTORS CORP]	1
WATER	INACTIVE INGREDIENT	059QF0KO0R	LIDOCAINE HYDROCHLORIDE SOLUTION [STAT RX LLC USA]	1
WATER	INACTIVE INGREDIENT	059QF0KO0R	LIDOCAINE HYDROCHLORIDE SOLUTION [PHYSICIANS TOTAL CARE, INC.]	1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
50383-775	LIDOCAINE HYDROCHLORIDE SOLUTION [AKORN]	22	Legacy NDC	20230120_ff6b27bc-2ed7-4292-b8c8-da910bf68167.zip
50383-775	DX1 ORAGENOMIC MEDICATED DNA COLLECTION SCREEN (LIDOCAINE HYDROCHLORIDE) KIT [IT3 MEDICAL LLC]	4	Legacy NDC	20220302_802fe200-8aad-464c-84f7-74d1809c4dd8.zip
50383-775	DX2 ORAGENOMIC MEDICATED DNA COLLECTION SCREEN (LIDOCAINE HYDROCHLORIDE) KIT [IT3 MEDICAL LLC]	4	Legacy NDC	20220302_f51bb899-9186-4654-afe6-e6f89ad8370d.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Lidocaine Hydrochloride	LIDOCAINE HYDROCHLORIDE	NuCare Pharmaceuticals,Inc.	5a41d694-4628-4911-e053-2991aa0a91e5	2024-08-14	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 040014 application number: ANDA040014

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
EC2CNF7XFP	LIDOCAINE HYDROCHLORIDE ANHYDROUS	73-78-9	LIDOCAINE HYDROCHLORIDE ANHYDROUS
V13007Z41A	LIDOCAINE HYDROCHLORIDE	6108-05-0	Lidocaine Hydrochloride

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
1010739	lidocaine HCl 2 % Mucous Membrane Topical Solution	PSN	10435379-1bb2-4023-98a7-ee4f28d620fd	8
1010739	lidocaine hydrochloride 20 MG/ML Mucous Membrane Topical Solution	SCD	10435379-1bb2-4023-98a7-ee4f28d620fd	8
1010739	lidocaine HCl 2 % Oral Topical Solution	SY	10435379-1bb2-4023-98a7-ee4f28d620fd	8
1010739	lidocaine HCl 2 % Oromucosal Solution	SY	10435379-1bb2-4023-98a7-ee4f28d620fd	8
1010739	lidocaine HCl 2 % Mucous Membrane Topical Solution	PSN	2de0a467-1338-4515-8a94-0d6d85e204ca	7
1010739	lidocaine hydrochloride 20 MG/ML Mucous Membrane Topical Solution	SCD	2de0a467-1338-4515-8a94-0d6d85e204ca	7
1010739	lidocaine HCl 2 % Oral Topical Solution	SY	2de0a467-1338-4515-8a94-0d6d85e204ca	7
1010739	lidocaine HCl 2 % Oromucosal Solution	SY	2de0a467-1338-4515-8a94-0d6d85e204ca	7
1010739	lidocaine HCl 2 % Mucous Membrane Topical Solution	PSN	5a41d694-4628-4911-e053-2991aa0a91e5	5
1010739	lidocaine hydrochloride 20 MG/ML Mucous Membrane Topical Solution	SCD	5a41d694-4628-4911-e053-2991aa0a91e5	5
1010739	lidocaine HCl 2 % Oral Topical Solution	SY	5a41d694-4628-4911-e053-2991aa0a91e5	5
1010739	lidocaine HCl 2 % Oromucosal Solution	SY	5a41d694-4628-4911-e053-2991aa0a91e5	5
1038558	benzalkonium chloride 0.13 % Medicated Pad	PSN	f51bb899-9186-4654-afe6-e6f89ad8370d	4
1038558	benzalkonium chloride 0.13 % Medicated Pad	PSN	802fe200-8aad-464c-84f7-74d1809c4dd8	4
1114098	glycerin 7.5 % Medicated Pad	PSN	f51bb899-9186-4654-afe6-e6f89ad8370d	4
1114098	glycerin 7.5 % Medicated Pad	PSN	802fe200-8aad-464c-84f7-74d1809c4dd8	4
1010739	lidocaine HCl 2 % Mucous Membrane Topical Solution	PSN	802fe200-8aad-464c-84f7-74d1809c4dd8	4
1010739	lidocaine HCl 2 % Mucous Membrane Topical Solution	PSN	f51bb899-9186-4654-afe6-e6f89ad8370d	4
1038558	benzalkonium chloride 1.3 MG/ML Medicated Pad	SCD	f51bb899-9186-4654-afe6-e6f89ad8370d	4
1038558	benzalkonium chloride 1.3 MG/ML Medicated Pad	SCD	802fe200-8aad-464c-84f7-74d1809c4dd8	4
1114098	glycerin 75 MG/ML Medicated Pad	SCD	f51bb899-9186-4654-afe6-e6f89ad8370d	4
1114098	glycerin 75 MG/ML Medicated Pad	SCD	802fe200-8aad-464c-84f7-74d1809c4dd8	4
1010739	lidocaine hydrochloride 20 MG/ML Mucous Membrane Topical Solution	SCD	802fe200-8aad-464c-84f7-74d1809c4dd8	4
1010739	lidocaine hydrochloride 20 MG/ML Mucous Membrane Topical Solution	SCD	f51bb899-9186-4654-afe6-e6f89ad8370d	4
1038558	benzalkonium chloride 0.13 % Topical Cloth	SY	802fe200-8aad-464c-84f7-74d1809c4dd8	4
1038558	benzalkonium chloride 0.13 % Topical Cloth	SY	f51bb899-9186-4654-afe6-e6f89ad8370d	4
1038558	benzalkonium chloride 0.13 % Topical Swab	SY	802fe200-8aad-464c-84f7-74d1809c4dd8	4
1038558	benzalkonium chloride 0.13 % Topical Swab	SY	f51bb899-9186-4654-afe6-e6f89ad8370d	4
1038558	benzalkonium chloride 0.13 GM per 100 GM Topical Pad	SY	802fe200-8aad-464c-84f7-74d1809c4dd8	4
1038558	benzalkonium chloride 0.13 GM per 100 GM Topical Pad	SY	f51bb899-9186-4654-afe6-e6f89ad8370d	4
1038558	benzalkonium chloride 0.13 GM per 100 GM Topical Swab	SY	f51bb899-9186-4654-afe6-e6f89ad8370d	4
1038558	benzalkonium chloride 0.13 GM per 100 GM Topical Swab	SY	802fe200-8aad-464c-84f7-74d1809c4dd8	4
1038558	benzalkonium chloride 1 ML per 750 ML Topical Swab	SY	f51bb899-9186-4654-afe6-e6f89ad8370d	4
1038558	benzalkonium chloride 1 ML per 750 ML Topical Swab	SY	802fe200-8aad-464c-84f7-74d1809c4dd8	4
1114098	glycerin 7.5 % Medicated Swab	SY	f51bb899-9186-4654-afe6-e6f89ad8370d	4
1114098	glycerin 7.5 % Medicated Swab	SY	802fe200-8aad-464c-84f7-74d1809c4dd8	4
1010739	lidocaine HCl 2 % Oral Topical Solution	SY	802fe200-8aad-464c-84f7-74d1809c4dd8	4
1010739	lidocaine HCl 2 % Oral Topical Solution	SY	f51bb899-9186-4654-afe6-e6f89ad8370d	4
1010739	lidocaine HCl 2 % Oromucosal Solution	SY	f51bb899-9186-4654-afe6-e6f89ad8370d	4
1010739	lidocaine HCl 2 % Oromucosal Solution	SY	802fe200-8aad-464c-84f7-74d1809c4dd8	4
1010739	lidocaine HCl 2 % Mucous Membrane Topical Solution	PSN	bb9ab676-fde0-4126-a0fa-7d67da5b613a	2
1010739	lidocaine HCl 2 % Mucous Membrane Topical Solution	PSN	49248d7b-06b8-6e90-e054-00144ff88e88	2
1010739	lidocaine hydrochloride 20 MG/ML Mucous Membrane Topical Solution	SCD	bb9ab676-fde0-4126-a0fa-7d67da5b613a	2
1010739	lidocaine hydrochloride 20 MG/ML Mucous Membrane Topical Solution	SCD	49248d7b-06b8-6e90-e054-00144ff88e88	2
1010739	lidocaine HCl 2 % Oral Topical Solution	SY	bb9ab676-fde0-4126-a0fa-7d67da5b613a	2
1010739	lidocaine HCl 2 % Oral Topical Solution	SY	49248d7b-06b8-6e90-e054-00144ff88e88	2
1010739	lidocaine HCl 2 % Oromucosal Solution	SY	bb9ab676-fde0-4126-a0fa-7d67da5b613a	2
1010739	lidocaine HCl 2 % Oromucosal Solution	SY	49248d7b-06b8-6e90-e054-00144ff88e88	2
1010739	lidocaine HCl 2 % Mucous Membrane Topical Solution	PSN	cdbc5206-a2da-4d71-920d-4d31d6702769	1
1010739	lidocaine HCl 2 % Mucous Membrane Topical Solution	PSN	26a20bc3-01ef-4ed7-e054-00144ff88e88	1
1010739	lidocaine HCl 2 % Mucous Membrane Topical Solution	PSN	8fcf95fa-b4e8-4c3c-8f59-23ca3d46377d	1
1010739	lidocaine hydrochloride 20 MG/ML Mucous Membrane Topical Solution	SCD	26a20bc3-01ef-4ed7-e054-00144ff88e88	1
1010739	lidocaine hydrochloride 20 MG/ML Mucous Membrane Topical Solution	SCD	cdbc5206-a2da-4d71-920d-4d31d6702769	1
1010739	lidocaine hydrochloride 20 MG/ML Mucous Membrane Topical Solution	SCD	8fcf95fa-b4e8-4c3c-8f59-23ca3d46377d	1
1010739	lidocaine HCl 2 % Oral Topical Solution	SY	26a20bc3-01ef-4ed7-e054-00144ff88e88	1
1010739	lidocaine HCl 2 % Oral Topical Solution	SY	cdbc5206-a2da-4d71-920d-4d31d6702769	1
1010739	lidocaine HCl 2 % Oral Topical Solution	SY	8fcf95fa-b4e8-4c3c-8f59-23ca3d46377d	1
1010739	lidocaine HCl 2 % Oromucosal Solution	SY	cdbc5206-a2da-4d71-920d-4d31d6702769	1
1010739	lidocaine HCl 2 % Oromucosal Solution	SY	8fcf95fa-b4e8-4c3c-8f59-23ca3d46377d	1
1010739	lidocaine HCl 2 % Oromucosal Solution	SY	26a20bc3-01ef-4ed7-e054-00144ff88e88	1

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
50383-775-04	50383077504	100 mL in 1 BOTTLE, PLASTIC (50383-775-04)	100 ml	1995-07-10	0000-00-00	No	No	Current
50383-775-15	50383077515	15 mL in 1 CUP, UNIT-DOSE	15 ml					Historical
50383-775-17	50383077517	4 TRAY in 1 CASE (50383-775-17) > 10 CUP, UNIT-DOSE in 1 TRAY > 15 mL in 1 CUP, UNIT-DOSE (50383-775-15)	4 tray	2015-03-24	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
LIDOCAINE HYDROCHLORIDE ORAL TOPICAL SOLUTION, USP (VISCOUS) 2%	NuCare Pharmaceuticals,Inc.	2024-08-14	HUMAN PRESCRIPTION DRUG LABEL	5
LIDOCAINE HYDROCHLORIDE ORAL TOPICAL SOLUTION, USP (VISCOUS) 2%	ATLANTIC BIOLOGICALS CORP.	2024-05-16	HUMAN PRESCRIPTION DRUG LABEL	7
LIDOCAINE HYDROCHLORIDE ORAL TOPICAL SOLUTION, USP (VISCOUS) 2%	RPK Pharmaceuticals, Inc.	2023-06-07	HUMAN PRESCRIPTION DRUG LABEL	4
LIDOCAINE HYDROCHLORIDE ORAL TOPICAL SOLUTION, USP (VISCOUS) 2%	Cardinal Health 107, LLC	2023-03-14	HUMAN PRESCRIPTION DRUG LABEL	8
LIDOCAINE HYDROCHLORIDE ORAL TOPICAL SOLUTION, USP (VISCOUS) 2%	A-S Medication Solutions	2023-02-04	HUMAN PRESCRIPTION DRUG LABEL	16
LIDOCAINE HYDROCHLORIDE ORAL TOPICAL SOLUTION, USP (VISCOUS) 2%	Akorn	2023-01-18	HUMAN PRESCRIPTION DRUG LABEL	22
LIDOCAINE HYDROCHLORIDE ORAL TOPICAL SOLUTION, USP (VISCOUS) 2%	Preferred Pharmaceuticals, Inc.	2022-07-21	HUMAN PRESCRIPTION DRUG LABEL	9
DX1 OraGenomic Medicated DNA Collection Screen	IT3 Medical LLC	2022-02-25	HUMAN PRESCRIPTION DRUG LABEL	4
DX2 OraGenomic Medicated DNA Collection Screen	IT3 Medical LLC	2022-02-25	HUMAN PRESCRIPTION DRUG LABEL	4
LIDOCAINE HYDROCHLORIDE ORAL TOPICAL SOLUTION, USP (VISCOUS) 2%	REMEDYREPACK INC.	2021-06-17	HUMAN PRESCRIPTION DRUG LABEL	3
Medicated Buccal DNA Collection Kit	NuCare Pharmaceuticals,Inc.	2021-05-04	HUMAN PRESCRIPTION DRUG LABEL	3
Medicated Buccal DNA Collection Kit 2	NuCare Pharmaceuticals,Inc.	2021-05-04	HUMAN PRESCRIPTION DRUG LABEL	2
LIDOCAINE ORAL TOPICAL SOLUTION	DIRECT RX	2020-01-20	HUMAN PRESCRIPTION DRUG LABEL	2
LIDOCAINE HYDROCHLORIDE ORAL TOPICAL SOLUTION, USP (VISCOUS) 2%	Unit Dose Services	2017-11-09	HUMAN PRESCRIPTION DRUG LABEL	8
Medicated DNA Collection Kit	TrueFit RX LLC \| TrueFit RX	2015-12-11	HUMAN PRESCRIPTION DRUG LABEL	1
Lidocaine Hydrochloride - LLC Federal Solutions \| Safecor Health, LLC	LLC Federal Solutions \| Safecor Health, LLC	2013-08-15	HUMAN PRESCRIPTION DRUG LABEL	2
LIDOCAINE HYDROCHLORIDE - Physicians Total Care, Inc.	Physicians Total Care, Inc.	2011-03-24	HUMAN PRESCRIPTION DRUG LABEL	1
LIDOCAINE HYDROCHLORIDE ORAL TOPICAL SOLUTION, USP (VISCOUS) 2%	Rebel Distributors Corp	2010-10-01	HUMAN PRESCRIPTION DRUG LABEL	1
LIDOCAINE HYDROCHLORIDE - STAT RX LLC USA	STAT RX LLC USA	2010-09-08	HUMAN PRESCRIPTION DRUG LABEL	1